To our knowledge, a regimen of oral steroids, given on the basis of a gradually decreasing dosage, combined with thoroughgoing rest is the most effective of all treatment measures attempted so far to control attacks of Ménière's disease. Experiences indicate, however, that there have been cases in which nystagmus long persisted in defiance of such a combined therapeutic regimen or, which after once having been alleviated, recurred in repeated episodes apparently unamenable to any therapeutic means. Our recent research efforts have led us to discover that imipramine, an antidepressant, when used in such less manageable cases, may provide an adequate control of long-persisting or frequently recurring nystagmus. During the year of 1981 a total of 84 patients were admitted to our hospital to receive treatment for attacks of Ménière's disease. Of these, 34 (40%) were given imipramine after other treatment measures had failed to control nystagmus. In 28 (82%) of them, imipramine therapy proved to be effective in controlling attacks in 3 of the remaining 6 the drug had to be discontinued owing to side effects, such as a rise in blood pressure, nightmares and auditory hallucinations, while in the other 3 the drug therapy provided an inadequate control of nystagmus, although it was uncertain whether this therapeutic failure was due to an insufficient dose of the drug or to some other cause. Worthy of particular note was that patients who required the use of imipramine, when compared with those who did not, were more frequently in their fifties or sixties and complained more often of sleep disturbance and notably of severe stiffness of shoulders and back. The dosage of imipramine ranged from 10 to 120 mg, most often being 30 mg. All patients in our series who complained of insomnia were given a dose of amitriptyline bofore retiring. Amitriptyline alone did not produce a nystagmussuppressing effect as seen with imipramine. Of particular interest was the following distinct relationship indicative of the effectiveness of imipramine observed in imipramine-requiring patients: the earlier the start of imipramine therapy, the shorter the duration of hospitalization, while inversely the later the drug was instituted, the longer was the period of hospital treatment required. Imipramine is one of the drugs that are useful for the treatment of Ménière's disease. The effectiveness of the drug in this disease can probably be explained by its ability to relieve the depressed state of Ménière's disease patients that supposedly obstructs biological responses thus leading to the cure of lesions in the inner ear responsible for the disease.
抄録全体を表示